REGULATION OF HUMAN PLATELET PROTHROMBINASE ACTIVITY

人血小板凝血酶原活性的调节

基本信息

项目摘要

Thrombin generation at the human platelet surface is effected through the assembly and function of the enzymatic complex, Prothrombinase, consisting of a 1:1 stoichiometric, Ca/2+ complex of the cofactor factor Va and the serine protease factor Xa. Subsequent to platelet activation, released platelet factor V(a) and/or plasma-derived factor Va bind to the platelet membrane surface and in so doing form at least part of the receptor for factor Xa. Thus, several protein/protein and protein/membrane interactions dictate functional complex assembly. A goal of this research project is to define how platelets actively participate in and regulate complex assembly. Because platelets have been shown to express the factor Xa membrane receptor Effector Protease Receptor-1 (EPR-1) following agonist-induced activation, substantial effort will be placed on defining its role in, and regulation of, a functional Prothrombinase complex. The platelet's ability to regulate events critical for enzyme complex assembly subsequent to agonist-induced activation will be assessed as well, specifically as related to 1) functional EPR-1 expression and 2) expression of a platelet factor Va molecule resistant to activated protein C inactivation, and perhaps other proteases as well. Because thrombin once formed positively regulates Prothrombinase complex assembly and function through platelet activation, a second goal is to understand how thrombin interactions with platelet membrane proteins affect its function. Effort will be placed on defining and isolating the thrombin high affinity binding site which appears to render the thrombin molecule transiently inactive and delineating the relationship of glycoprotein Ib/IX to this site. Finally, the observation that both a thrombomodulin-like molecule constitutively expressed on the platelet membrane and platelet-derived factor Va inhibit fibrinolysis through a thrombin-dependent mechanism will be explored, especially as related to the recently identified Thrombin Activatable Fibrinolysis Inhibitor (TAFI). The ultimate goal of this research project is to define the mechanisms by which platelets actively regulate both the generation and function of thrombin at their membrane surface. Defining the cellular and molecular events which regulate thrombin production is fundamental to our overall understanding of the hemostatic and thrombotic processes.
人血小板表面凝血酶的生成是通过

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paula Babiarz Tracy其他文献

Paula Babiarz Tracy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paula Babiarz Tracy', 18)}}的其他基金

Regulation of Human Platelet Prothrombinase
人血小板凝血酶原酶的调节
  • 批准号:
    7328152
  • 财政年份:
    2007
  • 资助金额:
    $ 25.4万
  • 项目类别:
Processed Defining Megakaryocyte Endocytosis of Factor V
因子 V 的巨核细胞内吞作用的加工定义
  • 批准号:
    6603437
  • 财政年份:
    2002
  • 资助金额:
    $ 25.4万
  • 项目类别:
Processed Defining Megakaryocyte Endocytosis of Factor V
因子 V 的巨核细胞内吞作用的加工定义
  • 批准号:
    6521965
  • 财政年份:
    2002
  • 资助金额:
    $ 25.4万
  • 项目类别:
Processed Defining Megakaryocyte Endocytosis of Factor V
因子 V 的巨核细胞内吞作用的加工定义
  • 批准号:
    6765970
  • 财政年份:
    2002
  • 资助金额:
    $ 25.4万
  • 项目类别:
Processed Defining Megakaryocyte Endocytosis of Factor V
因子 V 的巨核细胞内吞作用的加工定义
  • 批准号:
    6908190
  • 财政年份:
    2002
  • 资助金额:
    $ 25.4万
  • 项目类别:
REGULATION OF HUMAN PLATELET PROTHROMBINASE ACTIVITY
人血小板凝血酶原活性的调节
  • 批准号:
    6657103
  • 财政年份:
    2002
  • 资助金额:
    $ 25.4万
  • 项目类别:
REGULATION OF HUMAN PLATELET PROTHROMBINASE ACTIVITY
人血小板凝血酶原活性的调节
  • 批准号:
    6358057
  • 财政年份:
    2000
  • 资助金额:
    $ 25.4万
  • 项目类别:
REGULATION OF HUMAN PLATELET PROTHROMBINASE ACTIVITY
人血小板凝血酶原活性的调节
  • 批准号:
    6202327
  • 财政年份:
    1999
  • 资助金额:
    $ 25.4万
  • 项目类别:
REGULATION OF HUMAN PLATELET PROTHROMBINASE ACTIVITY
人血小板凝血酶原活性的调节
  • 批准号:
    6115930
  • 财政年份:
    1998
  • 资助金额:
    $ 25.4万
  • 项目类别:
MONOCYTE/MACROPHAGE REGULATION OF COAGULATION REACTIONS
凝血反应的单核细胞/巨噬细胞调节
  • 批准号:
    6115940
  • 财政年份:
    1998
  • 资助金额:
    $ 25.4万
  • 项目类别:

相似海外基金

Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10722686
  • 财政年份:
    2023
  • 资助金额:
    $ 25.4万
  • 项目类别:
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
  • 批准号:
    10571353
  • 财政年份:
    2023
  • 资助金额:
    $ 25.4万
  • 项目类别:
Elucidation of changes in electrical properties during the blood coagulation process and its use for measurement of blood coagulation status during extracorporeal circulation
阐明血液凝固过程中电特性的变化及其在体外循环期间血液凝固状态测量中的应用
  • 批准号:
    23K08266
  • 财政年份:
    2023
  • 资助金额:
    $ 25.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
SBIR Phase II: Innovative Platform for Low Volume Blood Coagulation Analysis
SBIR II 期:低容量凝血分析的创新平台
  • 批准号:
    2134020
  • 财政年份:
    2022
  • 资助金额:
    $ 25.4万
  • 项目类别:
    Cooperative Agreement
Construction of a multilayered network to represent blood coagulation process
构建代表血液凝固过程的多层网络
  • 批准号:
    22K12252
  • 财政年份:
    2022
  • 资助金额:
    $ 25.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Protein S Regulates Blood Coagulation by Inhibiting Factor IXa
Protein S 通过抑制 IXa 因子调节凝血
  • 批准号:
    10616732
  • 财政年份:
    2022
  • 资助金额:
    $ 25.4万
  • 项目类别:
Development of thrombus prevention technology for ECMO devices based on the blood coagulation mechanism caused by viral infections
基于病毒感染凝血机制的ECMO装置血栓预防技术开发
  • 批准号:
    21K08817
  • 财政年份:
    2021
  • 资助金额:
    $ 25.4万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10452687
  • 财政年份:
    2021
  • 资助金额:
    $ 25.4万
  • 项目类别:
SBIR Phase II: CoagCare-A POC Blood Coagulation Diagnostic Platform That Utilizes A Hand-held Meter and Mechanically Sensitive Test Strips for Broad Spectrum Hemostasis Monitoring
SBIR II 期:CoagCare - POC 凝血诊断平台,利用手持式仪表和机械敏感试纸条进行广谱止血监测
  • 批准号:
    2050272
  • 财政年份:
    2021
  • 资助金额:
    $ 25.4万
  • 项目类别:
    Cooperative Agreement
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
  • 批准号:
    10283268
  • 财政年份:
    2021
  • 资助金额:
    $ 25.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了